The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
Authors
Keywords
Hepatocellular carcinoma, Multivariate analysis, Hepatitis B virus, Hepatitis C virus, Cancer treatment, Lymphocytes, Albumins, Etiology
Journal
PLoS One
Volume 15, Issue 5, Pages e0232449
Publisher
Public Library of Science (PLoS)
Online
2020-05-08
DOI
10.1371/journal.pone.0232449
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Developments in predictive biomarkers for hepatocellular carcinoma therapy
- (2020) Andrea Casadei-Gardini et al. Expert Review of Anticancer Therapy
- Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin
- (2019) Serena De Matteis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment
- (2019) Sarah Berhane et al. BRITISH JOURNAL OF CANCER
- Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective Study
- (2019) Takeshi Hatanaka et al. INTERNAL MEDICINE
- ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
- (2019) Giorgia Marisi et al. Cancers
- Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials
- (2019) Giuseppe Cabibbo et al. Future Oncology
- Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
- (2019) Tim A. Labeur et al. LIVER INTERNATIONAL
- The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies
- (2018) Zhiling Wang et al. PLoS One
- Multicenter Prospective Study of Angiogenesis Polymorphism Validation in HCC Patients Treated with Sorafenib. An INNOVATE Study Protocol
- (2018) Andrea Casadei Gardini et al. TUMORI
- Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
- (2018) Giorgia Marisi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
- (2018) Tim A. Labeur et al. Liver Cancer
- Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale
- (2017) Andrea Casadei Gardini et al. EUROPEAN JOURNAL OF CANCER
- Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
- (2017) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007
- (2016) Jessica L. Petrick et al. INTERNATIONAL JOURNAL OF CANCER
- Angiogenesis polymorphisms profile in the prediction of clinical outcome of advanced HCC patients receiving sorafenib: Combined analysis of VEGF and HIF-1α—Final results of the ALICE-2 study.
- (2016) Luca Faloppi et al. JOURNAL OF CLINICAL ONCOLOGY
- Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New
- (2016) Luca Faloppi et al. Biomed Research International
- Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection
- (2015) Anthony W. H. Chan et al. ANNALS OF SURGICAL ONCOLOGY
- Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
- (2015) Massimo Iavarone et al. HEPATOLOGY
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
- (2015) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study
- (2014) Mario Scartozzi et al. INTERNATIONAL JOURNAL OF CANCER
- Associations Between Infiltrating Lymphocyte Subsets and Hepatocellular Carcinoma
- (2013) Cun-Li Guo et al. Asian Pacific Journal of Cancer Prevention
- Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second-line trial design
- (2013) Maria Reig et al. HEPATOLOGY
- Tumor-Associated Macrophage Promotes Tumor Progression via STAT3 Signaling in Hepatocellular Carcinoma
- (2013) Yohei Mano et al. PATHOBIOLOGY
- Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
- (2012) S Hagiwara et al. BRITISH JOURNAL OF CANCER
- A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)
- (2012) D J Pinato et al. BRITISH JOURNAL OF CANCER
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib
- (2012) Taiga Otsuka et al. HEPATOLOGY RESEARCH
- Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
- (2012) Olivier Mir et al. PLoS One
- Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score
- (2011) A. Hollebecque et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
- (2011) M. Pinter et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infiltrating Memory/Senescent T Cell Ratio Predicts Extrahepatic Metastasis of Hepatocellular Carcinoma
- (2011) Qiang Gao et al. ANNALS OF SURGICAL ONCOLOGY
- The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
- (2011) T. Yau et al. ONCOLOGIST
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Prognostic nutritional Index: A tool to predict the biological aggressiveness of gastric carcinoma
- (2010) Tadahiro Nozoe et al. SURGERY TODAY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started